EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Ospedale San Martino
Génova, ItaliaPublicaciones en colaboración con investigadores/as de Ospedale San Martino (9)
2023
-
Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence
Geburtshilfe und Frauenheilkunde, Vol. 84, Núm. 2, pp. 164-184
-
Spatial predictors of immunotherapy response in triple-negative breast cancer
Nature, Vol. 621, Núm. 7980, pp. 868-876
2022
2021
-
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Therapeutic Advances in Medical Oncology, Vol. 13
-
Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
npj Breast Cancer, Vol. 7, Núm. 1
-
Expected medium- And long-term impact of the COVID-19 outbreak in oncology
JCO Global Oncology, Vol. 7, pp. 162-172
2020
-
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
The Lancet Oncology, Vol. 21, Núm. 11, pp. 1455-1464
-
Standard anthracycline based versus docetaxel-capecitabine in early high clinical and/or genomic risk breast cancer in the EORTC 10041/BIG 3-04 MINDACT phase III trial
Journal of Clinical Oncology, Vol. 38, Núm. 11, pp. 1186-1197
2019
-
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Oncology, Vol. 20, Núm. 9, pp. 1226-1238